tiprankstipranks
PepGen Inc. Secures Funding to Advance Research Programs
Company Announcements

PepGen Inc. Secures Funding to Advance Research Programs

PepGen Inc. (PEPG) has released an update to notify the public and investors about an entry into a material definitive agreement.

Don't Miss Our Christmas Offers:

PepGen Inc. recently announced a significant financial move, entering an underwriting agreement to sell over 7.5 million shares at $10.635 each, aiming to raise around $76.4 million. This capital boost, set to close by February 9, 2024, is earmarked for the advancement of the company’s research and clinical programs, along with supporting its working capital and other corporate needs. Optimistically, this influx of funds is expected to sustain the company’s financial needs well into 2026, signaling a period of stability and growth for PepGen’s operations.

For further insights into PEPG stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TheFlyJefferies healthcare analyst holds an analyst/industry conference call
TheFlyPepGen clinical hold likely to be resolved quickly, says Leerink
TheFlyBofA downgrades PepGen to Underperform after clinical hold
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App